Search This Blog

Sunday, October 6, 2013

Oral Apremilast Significantly Improved Nail and Scalp Psoriasis and Health-Related Quality-of-Life Measures in Phase III ESTEEM 1 Study | Celgene Newsroom

Oral Apremilast Significantly Improved Nail and Scalp Psoriasis and Health-Related Quality-of-Life Measures in Phase III ESTEEM 1 Study | Celgene Newsroom

No comments:

Post a Comment

Note: Only a member of this blog may post a comment.